NASDAQ:WALD Waldencast Q1 2026 Earnings Report $1.34 -0.04 (-2.55%) As of 01:00 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings HistoryForecast Waldencast EPS ResultsActual EPSN/AConsensus EPS -$0.17Beat/MissN/AOne Year Ago EPSN/AWaldencast Revenue ResultsActual RevenueN/AExpected Revenue$65.37 millionBeat/MissN/AYoY Revenue GrowthN/AWaldencast Announcement DetailsQuarterQ1 2026Date9/8/2026TimeBefore Market OpensConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Waldencast Earnings HeadlinesWALDW Waldencast plc WT EXP 072727August 6, 2026 | seekingalpha.comWaldencast plc: Waldencast Announces Completion of the Sale of Obagi Medical to BridgepointJuly 31, 2026 | finanznachrichten.deU.S. Rival Just Raised the Stakes for This Quiet CompanyIran claims a new antimony discovery could represent 10 percent of known global supply. The U.S. barely produces any newly mined antimony of its own, a metal its military depends on. As Washington pours billions into securing critical supply chains, one North American company built around a historic antimony district is drawing fresh attention. Modern technology is helping it reassess what earlier miners overlooked. See how this quiet company fits into America's strategic materials story.September 8 at 1:00 AM | i2i Marketing Group, LLC (Ad)Waldencast Announces Completion of the Sale of Obagi Medical to BridgepointJuly 30, 2026 | globenewswire.comWaldencast plc: Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid GelJune 17, 2026 | finanznachrichten.deWaldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging DriveJune 15, 2026 | theglobeandmail.comSee More Waldencast Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Waldencast? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Waldencast and other key companies, straight to your email. Email Address About WaldencastWaldencast (NASDAQ:WALD) operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. The company is headquartered in White Plains, New York.View Waldencast ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 3 AI Optical Networking Stocks Positioned for the Data Center BuildoutSafety Stocks Are Not What They Used to Be: 4 Names Built for a Weaker DollarMarketBeat Week in Review – 08/31 - 09/04Why Guidewire’s Post-Earnings Plunge May Not LastPalo Alto vs. Zscaler: Which Cybersecurity Stock Looks Stronger After Earnings?Short Sellers Are Betting Against 3 AI Infrastructure Stocks—What Could Turn the Tide?Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal Upcoming Earnings Adobe (9/10/2026)Oracle (9/10/2026)FedEx (9/17/2026)Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
